Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNG2 | P59768 | 1/20 | 0.40 |
| ▸ | GNB1 | P62873 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | USP2 | O75604 | 2/20 | 0.39 |
| ▸ | RECQL | P46063 | 2/20 | 0.39 |
| ▸ | BLM | P54132 | 2/20 | 0.39 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | PRMT1 | Q99873 | 2/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | CDK2 | P24941 | 1/20 | 0.39 |
| ▸ | CHAT | P28329 | 1/20 | 0.39 |
| ▸ | BLVRB | P30043 | 1/20 | 0.39 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 3/20 | 0.38 |
| ▸ | CA12 | O43570 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29831001 | 1.00 | GNG2 (0.40) | GNG2GNB1MEN1KMT2AUSP2 | |
| SCHEMBL29838713 | 0.92 | MEN1 (0.39) | GNG2GNB1MEN1KMT2AUSP2 | |
| SCHEMBL29353753 | 0.92 | MEN1 (0.39) | GNG2GNB1MEN1KMT2AUSP2 | |
| SCHEMBL16118 | 0.92 | MEN1 (0.39) | GNG2GNB1MEN1KMT2AUSP2 | |
| SCHEMBL7970054 | 0.88 | GNG2 (0.40) | GNG2GNB1MEN1KMT2AUSP2 | |
| SCHEMBL20353144 | 0.86 | PRMT1 (0.44) | GNG2GNB1MEN1KMT2AUSP2 | |
| SCHEMBL1738599 | 0.86 | MEN1 (0.33) | GNG2GNB1MEN1KMT2AUSP2 | |
| SCHEMBL3358989 | 0.86 | MEN1 (0.33) | GNG2GNB1MEN1KMT2AUSP2 | |
| SCHEMBL203192 | 0.86 | GNG2 (0.43) | GNG2GNB1MEN1KMT2AUSP2 | |
| Succinimide SCHEMBL25268120 | 0.86 | MEN1 (0.35) | GNG2GNB1MEN1KMT2AUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 467 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4524568-A2 | METHODS FOR DETECTION OF RARE SUBPOPULATIONS OF CELLS AND HIGHLY PURIFIED COMPOSITIONS OF CELLS | Astellas Institute for Regenerative Medicine (US) | 2025-03-19 | — | — | EP | claimed |
| EP-3875599-B1 | METHODS FOR DETECTION OF RARE SUBPOPULATIONS OF CELLS AND HIGHLY PURIFIED COMPOSITIONS OF CELLS | ASTELLAS INST FOR REGENERATIVE MEDICINE (US) | 2024-12-11 | — | — | EP | claimed |
| US-20220146431-A1 | REAGENTS AND METHODS FOR DETECTING INFECTIOUS DISEASES | IONICA SCIENCES | 2022-05-12 | — | — | US | claimed |
| US-11300519-B2 | Reagents and methods for detecting infectious diseases | IONICA SCIENCES (US) | 2022-04-12 | — | — | US | claimed |
| EP-3514176-B1 | ANTIBODY SPECIFICALLY BINDING TO IL-17A AND FUNCTIONAL FRAGMENT THEREOF | BEIJING HANMI PHARMACEUTICAL CO LTD (CN) | 2021-12-15 | — | — | EP | claimed |
| EP-3875599-A1 | METHODS FOR DETECTION OF RARE SUBPOPULATIONS OF CELLS AND HIGHLY PURIFIED COMPOSITIONS OF CELLS | Astellas Institute for Regenerative Medicine (US) | 2021-09-08 | — | — | EP | claimed |
| EP-2596119-B1 | METHODS FOR DETECTION OF RARE SUBPOPULATIONS OF CELLS AND HIGHLY PURIFIED COMPOSITIONS OF CELLS | ASTELLAS INST FOR REGENERATIVE MEDICINE (US) | 2021-04-28 | — | — | EP | claimed |
| US-20190256588-A1 | ANTIBODY SPECIFICALLY BINDING TO IL-17A AND FUNCTIONAL FRAGMENT THEREOF | BEIJING HANMI PHARM. CO., LTD. (CN) | 2019-08-22 | — | — | US | claimed |
| EP-3514176-A1 | ANTIBODY SPECIFICALLY BINDING TO IL-17A AND FUNCTIONAL FRAGMENT THEREOF | Beijing Hanmi Pharmaceutical Co., Ltd. (CN) | 2019-07-24 | — | — | EP | claimed |
| EP-2764362-B1 | DYE CONJUGATED PEPTIDES FOR FLUORESCENT IMAGING | IMMUNOMEDICS INC (US) | 2018-09-05 | — | — | EP | claimed |
| WO-2009020680-A2 | MOLECULAR IMAGING OF LIVING SUBJECTS USING RAMAN SPECTROSCOPY AND LABELED RAMAN NANOPARTICLES | STANFORD UNIVERSITY (US) | 2009-02-12 | — | — | WO | claimed |
| EP-1937851-A2 | METHODS AND COMPOSITIONS FOR GENERATING BIOACTIVE ASSEMBLIES OF INCREASED COMPLEXITY AND USES | IBC Pharmaceuticals, Inc. (US) | 2008-07-02 | — | — | EP | claimed |
| EP-1874824-A2 | METHODS FOR GENERATING STABLY LINKED COMPLEXES COMPOSED OF HOMODIMERS, HOMOTETRAMERS OR DIMERS OF DIMERS AND USES | IBC Pharmaceuticals, Inc. (US) | 2008-01-09 | — | — | EP | claimed |
| US-20070264265-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION WITH CONJUGATED ANTIBODIES OR ANTIBODY FRAGMENTS | IMMUNOMEDICS, INC. | 2007-11-15 | — | — | US | claimed |
| WO-2007046893-A2 | METHODS FOR GENERATING BIOACTIVE ASSEMBLIES AND USES THEREOF | IBC PHARMACEUTICALS, INC. (US) | 2007-04-26 | — | — | WO | claimed |
| US-20070086942-A1 | Fusion propteins; homogeneous purity, and unaltered affinity, and can be produced in high yields without the requirement of extensive purification; stable in serum to allow in vivo applications | IBC PHARMACEUTICALS, INC. | 2007-04-19 | — | — | US | claimed |
| WO-2006107617-A2 | METHODS FOR GENERATING STABLY LINKED COMPLEXES COMPOSED OF HOMODIMERS, HOMOTETRAMERS OR DIMERS OF DIMERS AND USES | IBC PHARMACEUTICALS, INC. (US) | 2006-10-12 | — | — | WO | claimed |
| US-20060228357-A1 | dimerization and docking domains; fusion proteins | IBC PHARMACEUTICALS, INC. | 2006-10-12 | — | — | US | claimed |
| US-7057025-B2 | Binary probe and clamp composition | APPLERA CORPORATION (US) | 2006-06-06 | — | — | US | claimed |
| US-20060035217-A1 | BINARY PROBE AND CLAMP COMPOSITION. | PE CORPORATION (NY) (US) | 2006-02-16 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060035217-A1 | BINARY PROBE AND CLAMP COMPOSITION. | RNGTT, FEN1, POLL | GNG2 720/4885GNB1 816/4885MEN1 2953/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.